I am a passionate medical scientist with 18 years of extensive experience in cancer research, specializing in stomach and liver cancer. As an Immuno-Oncologist, my focus lies at the intersection of hematology and immunotherapy, particularly in treating Acute Myeloid Leukemia (AML).
Throughout my career, I have led groundbreaking research in developing immunomodulatory kits designed to precisely target blast cells and T-cell subtypes in AML patients. My expertise includes minimal residual disease (MRD) analyses, biomarker discovery, flow cytometry-based immune profiling, and in vitro diagnostics (IVD), contributing to advancements in precision medicine.
With a background in both research and clinical applications, I bridge the gap between oncology innovation and patient care, leveraging advanced preclinical models and translational medicine strategies. My work integrates novel biomarker-driven approaches, supporting the development of next-generation cancer immunotherapies and diagnostic solutions.